For transient downregulation of GLB1, a total of 30,000 control or 50,000 senescent A549 and SK‐MEL‐103 cells were plated per well in a 24‐well plate. The next day, cells were transfected with TriFECTa
® Kit DsiRNA Duplex siRNAs (Integrated DNA Technologies) hs.Ri.GLB1.13.1 (siRNA1), hs.Ri.GLB1.13.3 (siRNA2) or scrambled siRNA, using Lipotectamine RNAiMAX Reagent (Thermo Fisher Scientific) as per manufacturer's instructions. After 48 hr, RNA was extracted using the
RNeasy Mini Kit (Qiagen) and cDNA was synthesized with the
High‐Capacity RNA‐to‐cDNA™ Kit (Thermo Fisher Scientific).
Gene expression of GLB1 and ACTB genes was measured by quantitative real‐time PCR performed on a
QuantStudio thermocycler (Applied Biosystems) following Luna
® Universal qPCR Master Mix (New England Biolabs) protocol and amplification parameters, and using predesigned KiCqStart
® SYBR
® Green Primers H_GLB1_1 and H_ACTB_1 pairs (Sigma‐Aldrich). Relative quantification was carried out using 2−ΔΔCt methodology.
González‐Gualda E., Pàez‐Ribes M., Lozano‐Torres B., Macias D., Wilson JR I.I.I., González‐López C., Ou H., Mirón‐Barroso S., Zhang Z., Lérida‐Viso A., Blandez J.F., Bernardos A., Sancenón F., Rovira M., Fruk L., Martins C.P., Serrano M., Doherty G.J., Martínez‐Máñez R, & Muñoz‐Espín D. (2020). Galacto‐conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity. Aging Cell, 19(4), e13142.